Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Ether lipid metabolism	7/47	0.008364841000202511	1.0	0	0	2.978723404255319	14.249372624379504	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A;CHPT1;PLPP2;PLD2
Synthesis and degradation of ketone bodies	3/10	0.011479073193892965	1.0	0	0	5.999999999999999	26.803377741534163	HMGCL;HMGCS1;OXCT2
Fructose and mannose metabolism	5/33	0.02292040460454417	1.0	0	0	3.0303030303030303	11.441599195115412	GMPPB;ENOSF1;MPI;SORD;PFKP
Non-homologous end-joining	3/13	0.02446267254220388	1.0	0	0	4.615384615384615	17.125877967461363	FEN1;DNTT;NHEJ1
p53 signaling pathway	8/72	0.026917281476999108	1.0	0	0	2.222222222222222	8.033303921239105	CASP9;PIDD1;CCND2;CCND1;CCNG2;BAX;SFN;TP73
alpha-Linolenic acid metabolism	4/25	0.03399335307152362	1.0	0	0	3.1999999999999997	10.821088868398542	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A
Axon guidance	15/181	0.038246119201756835	1.0	0	0	1.6574585635359114	5.4094693634825655	SEMA4A;UNC5B;WNT5A;SEMA4C;SEMA4F;RHOD;MYL12B;ENAH;EFNA3;PPP3CB;RRAS;SRGAP3;EPHB4;EPHA2;PAK4
Linoleic acid metabolism	4/29	0.05462119016329882	1.0	0	0	2.758620689655172	8.020229995291032	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A
Pentose phosphate pathway	4/30	0.06063113352204076	1.0	0	0	2.6666666666666665	7.474524702251736	TALDO1;PRPS1L1;PGD;PFKP
Colorectal cancer	8/86	0.06555404339756293	1.0	0	0	1.8604651162790697	5.069544905119016	CASP9;SMAD2;TCF7L1;MAP2K2;CCND1;MSH2;BAX;EREG
Gastric cancer	12/149	0.07041999037716043	1.0	0	0	1.610738255033557	4.273736539980372	SMAD2;FRAT1;SHC2;TCF7L1;MAP2K2;WNT11;CCND1;CDX2;WNT5A;DVL2;BAX;FGF22
Ubiquitin mediated proteolysis	11/137	0.0821398931296985	1.0	0	0	1.605839416058394	4.013524990777432	PIAS4;CDC34;SYVN1;UBE2L6;WWP2;STUB1;BTRC;SKP2;UBE2J2;BIRC2;PIAS1
Terpenoid backbone biosynthesis	3/22	0.09471898702745883	1.0	0	0	2.727272727272727	6.427747642616689	HMGCS1;PMVK;ZMPSTE24
Complement and coagulation cascades	7/79	0.0997335943841466	1.0	0	0	1.7721518987341771	4.085257956571327	CFD;CR2;CR1;C4BPA;CD59;F2;SERPINA5
Thyroid cancer	4/37	0.11170784333278796	1.0	0	0	2.1621621621621623	4.739174827095357	TCF7L1;MAP2K2;CCND1;BAX
Hematopoietic cell lineage	8/97	0.11221289529851242	1.0	0	0	1.6494845360824741	3.608012142083881	CD2;CR2;CSF2;CR1;DNTT;CD59;CD24;EPOR
Protein processing in endoplasmic reticulum	12/165	0.12430307174535642	1.0	0	0	1.4545454545454544	3.0327746449727915	ERO1A;PPP1R15A;DNAJB1;PRKCSH;MAN1A2;SYVN1;BAX;HYOU1;RAD23A;STUB1;EIF2AK4;UBE2J2
Hepatocellular carcinoma	12/168	0.13644846024270998	1.0	0	0	1.4285714285714284	2.8454404518544685	SMAD2;GSTM4;FRAT1;SHC2;TCF7L1;MAP2K2;WNT11;CCND1;WNT5A;DVL2;BAX;SMARCA4
Ribosome	11/153	0.14464591030939392	1.0	0	0	1.437908496732026	2.7801479386463286	MRPL30;MRPL20;RPL41;RNA5S12;RPL18A;RPLP2;MRPS21;RPL38;MRPL36;MRPL9;FAU
Glutathione metabolism	5/56	0.14716977791840904	1.0	0	0	1.7857142857142856	3.4217292978951037	GSTM4;GPX4;GGT1;PGD;GCLM
Fat digestion and absorption	4/41	0.14721479282726987	1.0	0	0	1.951219512195122	3.7382684546071134	PLA2G2D;PLA2G2E;PLA2G2A;PLPP2
Hepatitis C	11/155	0.1538548184237674	1.0	0	0	1.4193548387096773	2.6566715414274853	CLDN6;CASP9;MAP2K2;CCND1;IFIT1B;IRF7;BAX;RIPK1;EIF2AK4;TYK2;PIAS1
Butanoate metabolism	3/28	0.16255339603696525	1.0	0	0	2.142857142857143	3.893033014692501	HMGCL;HMGCS1;OXCT2
Endometrial cancer	5/58	0.16328476821631294	1.0	0	0	1.7241379310344829	3.1245854451901107	CASP9;TCF7L1;MAP2K2;CCND1;BAX
Wnt signaling pathway	11/158	0.16821183822925043	1.0	0	0	1.3924050632911391	2.4820054015992006	VANGL1;FRAT1;PPP3CB;TCF7L1;CCND2;WNT11;CCND1;WNT5A;DVL2;BTRC;DKK1
Thiamine metabolism	2/15	0.17091154886530205	1.0	0	0	2.6666666666666665	4.710957638403321	ALPP;ALPI
Hippo signaling pathway	11/160	0.17813353768333626	1.0	0	0	1.375	2.3721799725993202	SMAD2;TCF7L1;CCND2;WNT11;CCND1;WNT5A;DVL2;BMP8A;BTRC;BIRC2;TP73
Necroptosis	11/162	0.18832482269682763	1.0	0	0	1.3580246913580245	2.267340406691085	ZBP1;HIST3H2A;MLKL;H2AFJ;FAF1;CHMP1B;CHMP3;BAX;RIPK1;TYK2;BIRC2
Synaptic vesicle cycle	6/78	0.19471584243590756	1.0	0	0	1.5384615384615385	2.5172523099552775	UNC13A;SLC6A9;SLC17A7;ATP6V1E1;AP2A2;CPLX4
Breast cancer	10/147	0.20122389293890539	1.0	0	0	1.3605442176870748	2.1814110144565944	FRAT1;SHC2;TCF7L1;MAP2K2;WNT11;CCND1;WNT5A;DVL2;BAX;FGF22
RNA degradation	6/79	0.20252260341125683	1.0	0	0	1.5189873417721518	2.425676623110086	BTG4;PAN2;DDX6;CNOT6L;EXOSC3;PFKP
Arachidonic acid metabolism	5/63	0.20636211070548938	1.0	0	0	1.5873015873015872	2.504956879983314	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A;GGT1
Basal cell carcinoma	5/63	0.20636211070548938	1.0	0	0	1.5873015873015872	2.504956879983314	TCF7L1;WNT11;WNT5A;DVL2;BAX
Cytosolic DNA-sensing pathway	5/63	0.20636211070548938	1.0	0	0	1.5873015873015872	2.504956879983314	ZBP1;CCL4;IRF7;RIPK1;POLR2L
Glycerophospholipid metabolism	7/97	0.21155364258994297	1.0	0	0	1.4432989690721647	2.241842635816865	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A;CHPT1;PLPP2;PLD2
Transcriptional misregulation in cancer	12/186	0.22160712364879417	1.0	0	0	1.2903225806451613	1.9443215202530542	ELK4;CSF2;CCND2;SLC45A3;SPINT1;KMT2A;MAX;LMO2;BAX;HIST2H3D;KLF3;PBX1
Arginine and proline metabolism	4/49	0.22855481299593203	1.0	0	0	1.6326530612244896	2.4097619846443257	P4HA1;CKB;ALDH18A1;CNDP1
Endocytosis	15/244	0.24090796823729388	1.0	0	0	1.2295081967213113	1.750008556915795	SMAD2;WIPF2;VPS37D;AP2A2;RNF41;PLD2;EHD1;GRK1;EHD2;ACAP3;DAB2;CAPZB;CHMP1B;CHMP3;SH3GL1
One carbon pool by folate	2/20	0.2641503607881601	1.0	0	0	2.0	2.66247357905395	MTHFD2;FTCD
Phosphonate and phosphinate metabolism	1/6	0.26493667555327055	1.0	0	0	3.333333333333333	4.427548139092615	CHPT1
Ras signaling pathway	14/232	0.27245022153486487	1.0	0	0	1.206896551724138	1.5693268075560824	SHC2;PLA2G2D;MAP2K2;PLA2G2E;PLA2G2A;PLD2;PLA2G16;EFNA3;RRAS;RIN1;FGF22;LAT;EPHA2;PAK4
Apoptosis	9/143	0.28725766333695896	1.0	0	0	1.2587412587412588	1.5701232390111806	CASP9;PIDD1;MAP2K2;DIABLO;CTSK;BAX;RIPK1;BIRC2;TUBA8
Adherens junction	5/72	0.2913681345785638	1.0	0	0	1.3888888888888888	1.712732977852415	SMAD2;TCF7L1;PTPRB;IQGAP1;NECTIN4
Epstein-Barr virus infection	12/201	0.3054856995308486	1.0	0	0	1.1940298507462686	1.4159430585223085	CASP9;ENTPD1;CR2;CCND2;PSMD4;CCND1;PSMD2;IRF7;BAX;RIPK1;TYK2;SKP2
Histidine metabolism	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	CNDP1;FTCD
IL-17 signaling pathway	6/93	0.32110195783620454	1.0	0	0	1.2903225806451613	1.465802039518082	CSF2;JUND;MMP1;IL17D;IL17C;IL17RA
Small cell lung cancer	6/93	0.32110195783620454	1.0	0	0	1.2903225806451613	1.465802039518082	CASP9;CCND1;MAX;BAX;SKP2;BIRC2
Riboflavin metabolism	1/8	0.33662794865636386	1.0	0	0	2.5	2.721942421048515	FLAD1
Bladder cancer	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	MAP2K2;CCND1;MMP1
NF-kappa B signaling pathway	6/95	0.33896434675202747	1.0	0	0	1.263157894736842	1.3665604407859686	PIAS4;PIDD1;CCL4;RIPK1;BIRC2;LAT
VEGF signaling pathway	4/59	0.3411916398273588	1.0	0	0	1.3559322033898304	1.458048767361736	CASP9;PPP3CB;SHC2;MAP2K2
Prostate cancer	6/97	0.3569285827398046	1.0	0	0	1.2371134020618557	1.2744984316239885	CASP9;TCF7L1;MAP2K2;CCND1;CREB3L3;SPINT1
Cushing syndrome	9/155	0.37149900230097443	1.0	0	0	1.1612903225806452	1.1499202456539444	TCF7L1;MAP2K2;WNT11;CCND1;CREB3L3;KMT2A;WNT5A;DVL2;PBX1
Folate biosynthesis	2/26	0.3759320092394212	1.0	0	0	1.5384615384615385	1.5051491975911149	ALPP;ALPI
Measles	8/138	0.38588815366024015	1.0	0	0	1.1594202898550725	1.1040089378109808	CASP9;CCND2;CCND1;IRF7;BAX;EIF2AK4;TYK2;TP73
Melanogenesis	6/101	0.39300017337866283	1.0	0	0	1.188118811881188	1.109637892212941	TCF7L1;MAP2K2;WNT11;CREB3L3;WNT5A;DVL2
Collecting duct acid secretion	2/27	0.39397603610044213	1.0	0	0	1.4814814814814814	1.3799484349837585	SLC4A1;ATP6V1E1
Peroxisome	5/83	0.40119924980674115	1.0	0	0	1.2048192771084336	1.1003579430959414	HMGCL;SLC25A17;PMVK;HACL1;PEX14
Taste transduction	5/83	0.40119924980674115	1.0	0	0	1.2048192771084336	1.1003579430959414	TAS2R7;HCN4;TAS2R8;HTR3C;TRPM5
Focal adhesion	11/199	0.41044808530199395	1.0	0	0	1.1055276381909547	0.9844788015892296	SHC2;CCND2;CCND1;ITGA11;PARVA;PARVB;COL9A2;BIRC2;BCAR1;MYL12B;PAK4
Human T-cell leukemia virus 1 infection	12/219	0.4145128742255005	1.0	0	0	1.095890410958904	0.9650972550550574	ELK4;SMAD2;VAC14;PPP3CB;CRTC2;RANBP3;CSF2;CCND2;MAP2K2;CREB3L3;CCND1;BAX
Hedgehog signaling pathway	3/47	0.4196120451603213	1.0	0	0	1.276595744680851	1.1086272722292005	CCND2;CCND1;BTRC
Toll-like receptor signaling pathway	6/104	0.4200266801120024	1.0	0	0	1.1538461538461537	1.0008888988224178	MAP2K2;CTSK;CCL4;IRF7;CCL3;RIPK1
Acute myeloid leukemia	4/66	0.421430857889875	1.0	0	0	1.2121212121212122	1.0473933978386722	TCF7L1;CSF2;MAP2K2;CCND1
Non-small cell lung cancer	4/66	0.421430857889875	1.0	0	0	1.2121212121212122	1.0473933978386722	CASP9;MAP2K2;CCND1;BAX
JAK-STAT signaling pathway	9/162	0.4217675606505793	1.0	0	0	1.111111111111111	0.959223245377778	PIAS4;CSF2;CCND2;IFNL1;CCND1;TYK2;IL17D;EPOR;PIAS1
Viral carcinogenesis	11/201	0.42334810143404067	1.0	0	0	1.0945273631840795	0.940812491424585	VAC14;GTF2A2;CCND2;CREB3L3;CCND1;IRF7;BAX;SKP2;HIST1H2BB;HIST1H4E;HDAC7
Cell cycle	7/124	0.42665940706055616	1.0	0	0	1.129032258064516	0.9616749321100159	SMAD2;CCND2;TFDP1;CCND1;SFN;CDC7;SKP2
Taurine and hypotaurine metabolism	1/11	0.43128166280518815	1.0	0	0	1.8181818181818181	1.529079804244035	GGT1
Valine, leucine and isoleucine degradation	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	HMGCL;HMGCS1;OXCT2
Rap1 signaling pathway	11/206	0.45554510156466316	1.0	0	0	1.0679611650485437	0.8396957347976332	MAGI1;EFNA3;SIPA1L1;MAP2K2;RRAS;SIPA1L2;RAP1GAP;FGF22;LAT;BCAR1;EPHA2
Autophagy	7/128	0.45946687100202477	1.0	0	0	1.09375	0.8505967287493645	MAP2K2;RRAS;ATG2A;ATG4C;ULK2;EIF2AK4;ATG12
Prolactin signaling pathway	4/70	0.4662992293725246	1.0	0	0	1.1428571428571428	0.8719174032140833	SHC2;CCND2;MAP2K2;CCND1
RIG-I-like receptor signaling pathway	4/70	0.4662992293725246	1.0	0	0	1.1428571428571428	0.8719174032140833	SIKE1;IRF7;RIPK1;ATG12
Amyotrophic lateral sclerosis (ALS)	3/51	0.47268752481329424	1.0	0	0	1.176470588235294	0.881553803378603	CASP9;PPP3CB;BAX
TNF signaling pathway	6/110	0.4734883847029237	1.0	0	0	1.0909090909090908	0.8155940698683591	CSF2;CREB3L3;MLKL;RIPK1;SELE;BIRC2
Relaxin signaling pathway	7/130	0.47572414988888423	1.0	0	0	1.0769230769230769	0.8000645797585316	SMAD2;SHC2;MAP2K2;CREB3L3;MMP1;RLN3;RLN1
B cell receptor signaling pathway	4/71	0.47732691074516864	1.0	0	0	1.1267605633802817	0.8332999159019496	IFITM1;PPP3CB;CR2;MAP2K2
Tight junction	9/170	0.47892097047619975	1.0	0	0	1.0588235294117647	0.7795267239713987	MAGI1;CLDN6;CCND1;HCLS1;ARHGAP17;CGNL1;MYL12B;TUBA8;RAB8B
Rheumatoid arthritis	5/91	0.48023571472567267	1.0	0	0	1.0989010989010988	0.8060200255732013	CSF2;MMP1;CTSK;CCL3;ATP6V1E1
Bile secretion	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	SLC9A3;SCT;AQP8;SLC9A1
Melanoma	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	MAP2K2;CCND1;BAX;FGF22
FoxO signaling pathway	7/132	0.49185149962456454	1.0	0	0	1.0606060606060606	0.7525831919041477	SMAD2;CCND2;MAP2K2;CCND1;CCNG2;SKP2;ATG12
Base excision repair	2/33	0.496510840077104	1.0	0	0	1.2121212121212122	0.8486666215153239	FEN1;UNG
Regulation of actin cytoskeleton	11/214	0.5064833279676546	1.0	0	0	1.02803738317757	0.6993366908306636	ENAH;MAP2K2;RRAS;ITGA11;IQGAP1;F2;FGF22;BCAR1;MYL12B;PAK4;SLC9A1
Bacterial invasion of epithelial cells	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	SHC2;HCLS1;ELMO3;BCAR1
Glioma	4/75	0.520490485053102	1.0	0	0	1.0666666666666667	0.6965159162578138	SHC2;MAP2K2;CCND1;BAX
Pancreatic cancer	4/75	0.520490485053102	1.0	0	0	1.0666666666666667	0.6965159162578138	CASP9;SMAD2;CCND1;BAX
Legionellosis	3/55	0.5234350892650081	1.0	0	0	1.0909090909090908	0.706191545588209	CASP9;EEF1G;CR1
Prion diseases	2/35	0.5281643594916885	1.0	0	0	1.1428571428571428	0.7295402934851642	MAP2K2;BAX
Chronic myeloid leukemia	4/76	0.531017425175643	1.0	0	0	1.0526315789473684	0.666274150005563	SHC2;MAP2K2;CCND1;BAX
Pancreatic secretion	5/98	0.5463079186398003	1.0	0	0	1.0204081632653061	0.616910723108701	PLA2G2D;PLA2G2E;SCT;PLA2G2A;SLC9A1
Signaling pathways regulating pluripotency of stem cells	7/139	0.546960679882136	1.0	0	0	1.0071942446043165	0.6077192138852752	SMAD2;MAP2K2;WNT11;WNT5A;PCGF3;DVL2;SMAD9
Pyrimidine metabolism	3/57	0.5477812798713707	1.0	0	0	1.0526315789473684	0.6335570484502631	ENTPD1;UCK2;CANT1
Alcoholism	9/180	0.5483170890648543	1.0	0	0	1.0	0.6009015296953345	SHC2;HIST3H2A;CREB3L3;H2AFJ;HAT1;HIST1H2BB;HIST2H3D;HIST1H4E;HDAC7
Cellular senescence	8/160	0.5511758519618988	1.0	0	0	1.0	0.5957013701808717	SMAD2;PPP3CB;CCND2;MAP2K2;CCND1;RRAS;BTRC;HIPK3
African trypanosomiasis	2/37	0.5584386214472209	1.0	0	0	1.0810810810810811	0.6298492599382502	NPPA;SELE
Aldosterone-regulated sodium reabsorption	2/37	0.5584386214472209	1.0	0	0	1.0810810810810811	0.6298492599382502	HSD11B2;SFN
AMPK signaling pathway	6/120	0.558921512029944	1.0	0	0	1.0	0.5817462235027698	SREBF1;CRTC2;CCND1;CREB3L3;EEF2;PFKP
T cell receptor signaling pathway	5/101	0.5733754172932677	1.0	0	0	0.9900990099009901	0.5507075230503586	PPP3CB;CSF2;MAP2K2;LAT;PAK4
Human papillomavirus infection	16/330	0.5868541173445081	1.0	0	0	0.9696969696969696	0.5168281332870329	MAGI1;TCF7L1;MAP2K2;WNT5A;TYK2;CCND2;WNT11;CREB3L3;CCND1;ITGA11;DVL2;BAX;COL9A2;ATP6V1E1;HES2;HES4
Ferroptosis	2/40	0.60119891797304	1.0	0	0	1.0	0.5088294208836465	GPX4;GCLM
ErbB signaling pathway	4/85	0.6201271748700885	1.0	0	0	0.9411764705882353	0.4497230129121684	SHC2;MAP2K2;EREG;PAK4
cAMP signaling pathway	10/212	0.6203155438584437	1.0	0	0	0.9433962264150944	0.4504971591535261	HCN4;MAP2K2;CREB3L3;RRAS;NPPA;PDE3A;GHRL;SLC9A1;PLD2;GIP
Th17 cell differentiation	5/107	0.6248402405451496	1.0	0	0	0.9345794392523363	0.43949465144730016	SMAD2;PPP3CB;TYK2;IL17D;LAT
Salmonella infection	4/86	0.6293463661035574	1.0	0	0	0.9302325581395349	0.4307660579611482	CSF2;CCL4;CCL3;RILP
Purine metabolism	6/129	0.6298141258718173	1.0	0	0	0.9302325581395349	0.4300749222582539	ENTPD1;CANT1;PDE3A;AMPD1;PRPS1L1;HDDC3
Central carbon metabolism in cancer	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	MAP2K2;SIRT6;PFKP
Shigellosis	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	HCLS1;ELMO3;BTRC
mTOR signaling pathway	7/152	0.6417021441357289	1.0	0	0	0.9210526315789472	0.4086075302976567	MAP2K2;WNT11;WNT5A;DVL2;ULK2;ATP6V1E1;SKP2
Arginine biosynthesis	1/21	0.6596258189717179	1.0	0	0	0.9523809523809523	0.3962690911289506	GPT2
TGF-beta signaling pathway	4/90	0.6647641861492688	1.0	0	0	0.8888888888888888	0.362953696452133	SMAD2;TFDP1;BMP8A;SMAD9
Basal transcription factors	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	GTF2A2;TAF13
Proteasome	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	PSMD4;PSMD2
Fc epsilon RI signaling pathway	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	CSF2;MAP2K2;LAT
Renin secretion	3/69	0.6772948191670352	1.0	0	0	0.8695652173913043	0.338824888725687	PPP3CB;NPPA;PDE3A
Proteoglycans in cancer	9/201	0.6798088518130012	1.0	0	0	0.8955223880597014	0.34562115277886923	SMAD2;MAP2K2;WNT11;RRAS;CCND1;WNT5A;HCLS1;IQGAP1;SLC9A1
Apelin signaling pathway	6/137	0.6868931771447399	1.0	0	0	0.8759124087591241	0.3289721085839843	MYL4;SMAD2;MAP2K2;CCND1;RRAS;SLC9A1
Cysteine and methionine metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	MAT1A;GCLM
Sphingolipid metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	SMPD3;PLPP2
Mannose type O-glycan biosynthesis	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	B3GAT1
Mismatch repair	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	MSH2
Proximal tubule bicarbonate reclamation	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	SLC9A3
Human cytomegalovirus infection	10/225	0.6932935578880997	1.0	0	0	0.8888888888888888	0.32560156891656883	CASP9;PPP3CB;MAP2K2;CREB3L3;CCND1;CCL4;CCL3;BAX;RIPK1;BCAR1
Thyroid hormone signaling pathway	5/116	0.6946174064374339	1.0	0	0	0.8620689655172414	0.3141328270082842	CASP9;MAP2K2;CCND1;PFKP;SLC9A1
PI3K-Akt signaling pathway	16/354	0.6969120694032426	1.0	0	0	0.903954802259887	0.32641449219063584	MAGI1;CRTC2;MAP2K2;EPOR;EREG;CASP9;TCL1A;EFNA3;CCND2;CREB3L3;CCND1;ITGA11;THEM4;COL9A2;FGF22;EPHA2
Amino sugar and nucleotide sugar metabolism	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	GMPPB;MPI
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/72	0.7050123870135998	1.0	0	0	0.8333333333333333	0.2912832550768055	TCF7L1;ACTN2;ITGA11
Malaria	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	CR1;SELE
Hepatitis B	7/163	0.7121164303112548	1.0	0	0	0.8588957055214724	0.29160699221433833	SMAD2;CASP9;MAP2K2;CREB3L3;IRF7;BAX;TYK2
Kaposi sarcoma-associated herpesvirus infection	8/186	0.7176638068592711	1.0	0	0	0.8602150537634409	0.28537983239781983	CASP9;PPP3CB;CSF2;MAP2K2;CCND1;IRF7;BAX;TYK2
N-Glycan biosynthesis	2/50	0.7209459791839935	1.0	0	0	0.7999999999999999	0.2617528554824198	MAN1A2;ALG14
Vibrio cholerae infection	2/50	0.7209459791839935	1.0	0	0	0.7999999999999999	0.2617528554824198	ERO1A;ATP6V1E1
Inositol phosphate metabolism	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	ITPKB;IMPA2;PLCH2
PPAR signaling pathway	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	MMP1;PLIN2;PLIN5
Mineral absorption	2/51	0.7310789651903944	1.0	0	0	0.7843137254901961	0.24567356984329963	SLC9A3;MT1X
Choline metabolism in cancer	4/99	0.7357196016371502	1.0	0	0	0.8080808080808081	0.24800501727640314	MAP2K2;CHPT1;PLPP2;PLD2
AGE-RAGE signaling pathway in diabetic complications	4/100	0.7428559954663433	1.0	0	0	0.7999999999999999	0.23780245442692988	SMAD2;CCND1;BAX;SELE
Fatty acid elongation	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	THEM4
Glycosaminoglycan biosynthesis	2/53	0.7504077852742062	1.0	0	0	0.7547169811320754	0.21670830680118947	CHST6;B3GAT3
Phospholipase D signaling pathway	6/148	0.7553912967971983	1.0	0	0	0.8108108108108109	0.22744815412465288	SHC2;MAP2K2;RRAS;F2;PLPP2;PLD2
Influenza A	7/171	0.7571154708373605	1.0	0	0	0.8187134502923976	0.22779842084269228	CASP9;DNAJB1;MAP2K2;TMPRSS4;IRF7;EIF2AK4;TYK2
Phototransduction	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	GRK1
Glucagon signaling pathway	4/103	0.7633839575456066	1.0	0	0	0.7766990291262135	0.20970419679401037	CRTC2;PPP3CB;CREB3L3;SIK2
Osteoclast differentiation	5/127	0.7670589994510474	1.0	0	0	0.7874015748031495	0.20881225056066524	PPP3CB;JUND;CTSK;TYK2;LILRB4
Pathogenic Escherichia coli infection	2/55	0.7685284162153218	1.0	0	0	0.7272727272727272	0.1914747203489268	HCLS1;TUBA8
Regulation of lipolysis in adipocytes	2/55	0.7685284162153218	1.0	0	0	0.7272727272727272	0.1914747203489268	PLA2G16;NPPA
Oxytocin signaling pathway	6/153	0.7826524992964198	1.0	0	0	0.7843137254901961	0.19220901041264157	KCNJ5;PPP3CB;MAP2K2;CCND1;NPPA;EEF2
Chemical carcinogenesis	3/82	0.7842396846897038	1.0	0	0	0.7317073170731706	0.17783457445402553	SULT1A1;GSTM4;SULT1A2
ECM-receptor interaction	3/82	0.7842396846897038	1.0	0	0	0.7317073170731706	0.17783457445402553	SV2B;ITGA11;COL9A2
Glyoxylate and dicarboxylate metabolism	1/30	0.785605993701368	1.0	0	0	0.6666666666666666	0.16086659500936684	GRHPR
Nicotinate and nicotinamide metabolism	1/30	0.785605993701368	1.0	0	0	0.6666666666666666	0.16086659500936684	NADK
Natural killer cell mediated cytotoxicity	5/131	0.7899190896828266	1.0	0	0	0.7633587786259541	0.18001889838867802	SHC2;PPP3CB;CSF2;MAP2K2;LAT
Vascular smooth muscle contraction	5/132	0.7953524382434503	1.0	0	0	0.7575757575757576	0.17346207880243836	PLA2G2D;MAP2K2;PLA2G2E;NPPA;PLA2G2A
Circadian rhythm	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	BTRC
Galactose metabolism	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	PFKP
RNA polymerase	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	POLR2L
beta-Alanine metabolism	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	CNDP1
Systemic lupus erythematosus	5/133	0.8006749703651704	1.0	0	0	0.7518796992481203	0.1671430030702634	HIST3H2A;H2AFJ;HIST1H2BB;HIST2H3D;HIST1H4E
Lysine degradation	2/59	0.8013529002820844	1.0	0	0	0.6779661016949152	0.15013820630777816	KMT2A;KMT5A
Viral myocarditis	2/59	0.8013529002820844	1.0	0	0	0.6779661016949152	0.15013820630777816	CASP9;CCND1
Leukocyte transendothelial migration	4/112	0.8173248241169633	1.0	0	0	0.7142857142857142	0.14408477257015773	CLDN6;RHOH;BCAR1;MYL12B
MicroRNAs in cancer	12/299	0.8206716096774825	1.0	0	0	0.802675585284281	0.1586345721141662	EFNA3;SLC45A3;CCND2;MAP2K2;CCND1;MIR101-2;MIR26A2;MIR200A;MIR200B;MIR133B;RECK;PAK4
Estrogen signaling pathway	5/137	0.8208780761188903	1.0	0	0	0.72992700729927	0.14407349424250715	KCNJ5;SHC2;MAP2K2;CREB3L3;KRT17
Pentose and glucuronate interconversions	1/34	0.8254324369271197	1.0	0	0	0.588235294117647	0.11285168470716885	SORD
Glutamatergic synapse	4/114	0.8278334479918896	1.0	0	0	0.7017543859649122	0.13259178568312602	PPP3CB;SLC17A7;PLD2;SHANK1
Alanine, aspartate and glutamate metabolism	1/35	0.8341755971925006	1.0	0	0	0.5714285714285714	0.103606486053202	GPT2
Protein digestion and absorption	3/90	0.8341902087803339	1.0	0	0	0.6666666666666666	0.120862556363351	SLC9A3;COL9A2;PGA5
Fc gamma R-mediated phagocytosis	3/91	0.8396768561291149	1.0	0	0	0.6593406593406593	0.11521197114942941	PLPP2;LAT;PLD2
DNA replication	1/36	0.8424812699182175	1.0	0	0	0.5555555555555555	0.09522436030767889	FEN1
Cortisol synthesis and secretion	2/65	0.8428493095437481	1.0	0	0	0.6153846153846154	0.10521051812214251	CREB3L3;PBX1
Parkinson disease	5/142	0.8437741668121552	1.0	0	0	0.704225352112676	0.11962703877312425	CASP9;NDUFB10;LRRK2;UBE2L6;UBE2J2
Th1 and Th2 cell differentiation	3/92	0.845005864491722	1.0	0	0	0.6521739130434782	0.10983372484053684	PPP3CB;TYK2;LAT
Aminoacyl-tRNA biosynthesis	2/66	0.8489478345965421	1.0	0	0	0.6060606060606061	0.09924699267132996	YARS;PARS2
Primary immunodeficiency	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	UNG
Neurotrophin signaling pathway	4/119	0.851921877903696	1.0	0	0	0.6722689075630252	0.10773811694664917	SHC2;MAP2K2;BAX;TP73
Huntington disease	7/193	0.8541653276195655	1.0	0	0	0.7253886010362693	0.11434337648580056	CASP9;CREB3L3;NDUFB10;BAX;AP2A2;RCOR1;POLR2L
Long-term potentiation	2/67	0.8548301611907013	1.0	0	0	0.5970149253731343	0.0936432666623936	PPP3CB;MAP2K2
Cell adhesion molecules (CAMs)	5/145	0.8563159481665291	1.0	0	0	0.689655172413793	0.10697646387244193	CLDN6;CD2;VTCN1;SELE;MPZL1
Amphetamine addiction	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	PPP3CB;CREB3L3
Pyruvate metabolism	1/39	0.8649866555134298	1.0	0	0	0.5128205128205128	0.07438010221608295	GRHPR
Renal cell carcinoma	2/69	0.8659715129706728	1.0	0	0	0.5797101449275363	0.08342218313842696	MAP2K2;PAK4
Glycine, serine and threonine metabolism	1/40	0.8717504251826977	1.0	0	0	0.5	0.06862605284591321	GRHPR
Nicotine addiction	1/40	0.8717504251826977	1.0	0	0	0.5	0.06862605284591321	SLC17A7
Aldosterone synthesis and secretion	3/98	0.8738518002871013	1.0	0	0	0.6122448979591836	0.08255784648566498	KCNJ5;CREB3L3;NPPA
MAPK signaling pathway	11/295	0.8770572182883419	1.0	0	0	0.7457627118644068	0.09783142378954804	ELK4;MAP4K2;PPP3CB;EFNA3;JUND;MAP2K2;RRAS;MAX;FGF22;EREG;EPHA2
Ribosome biogenesis in eukaryotes	3/101	0.8864097011888528	1.0	0	0	0.594059405940594	0.07162931796059352	RNA5S12;REXO1;NOB1
Metabolism of xenobiotics by cytochrome P450	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	GSTM4;AKR7A3
Gastric acid secretion	2/75	0.8948461559431564	1.0	0	0	0.5333333333333333	0.0592551830845253	KCNJ10;SLC9A1
Vasopressin-regulated water reabsorption	1/44	0.8955853061573006	1.0	0	0	0.45454545454545453	0.05012627322480098	CREB3L3
Thermogenesis	8/231	0.8962982682392014	1.0	0	0	0.6926406926406926	0.07583171099049017	COX19;CREB3L3;NDUFB10;NPPA;ZNF516;BMP8A;SIRT6;SMARCA4
C-type lectin receptor signaling pathway	3/104	0.8978388517991447	1.0	0	0	0.5769230769230769	0.0621719302632217	PPP3CB;RRAS;IL17D
ABC transporters	1/45	0.9008174591944802	1.0	0	0	0.4444444444444444	0.046423395514619575	ABCA7
Glycosphingolipid biosynthesis	1/45	0.9008174591944802	1.0	0	0	0.4444444444444444	0.046423395514619575	B4GALNT1
Parathyroid hormone synthesis, secretion and action	3/106	0.9048723287754362	1.0	0	0	0.5660377358490566	0.05658193494921566	JUND;CREB3L3;PLD2
Cardiac muscle contraction	2/78	0.9070080241695482	1.0	0	0	0.5128205128205128	0.0500533240880421	MYL4;SLC9A1
Human immunodeficiency virus 1 infection	7/212	0.9102489016760925	1.0	0	0	0.660377358490566	0.06210003677512062	CASP9;PPP3CB;MAP2K2;BAX;RIPK1;BTRC;PAK4
Nucleotide excision repair	1/47	0.9105090567783704	1.0	0	0	0.42553191489361697	0.03989422673431822	RAD23A
Drug metabolism	3/108	0.9114649563237461	1.0	0	0	0.5555555555555555	0.051501184313357255	GSTM4;UCK2;CES2
Insulin resistance	3/108	0.9114649563237461	1.0	0	0	0.5555555555555555	0.051501184313357255	SREBF1;CRTC2;CREB3L3
Endocrine and other factor-regulated calcium reabsorption	1/48	0.914994048233663	1.0	0	0	0.41666666666666663	0.03701571599601437	AP2A2
Notch signaling pathway	1/48	0.914994048233663	1.0	0	0	0.41666666666666663	0.03701571599601437	DVL2
Chemokine signaling pathway	6/190	0.9179445909739374	1.0	0	0	0.631578947368421	0.054074683325986896	GRK1;SHC2;CCL4;CCL3;CCL18;BCAR1
Cocaine addiction	1/49	0.919254474341766	1.0	0	0	0.4081632653061224	0.034364200583535946	CREB3L3
cGMP-PKG signaling pathway	5/166	0.9224682232595534	1.0	0	0	0.6024096385542168	0.04861587348906672	PPP3CB;MAP2K2;CREB3L3;NPPA;PDE3A
Cholesterol metabolism	1/50	0.9233015685863551	1.0	0	0	0.39999999999999997	0.03191974852547144	MYLIP
Serotonergic synapse	3/113	0.9261680268010687	1.0	0	0	0.5309734513274336	0.04072545470868394	KCNJ5;CYP4X1;HTR3C
Toxoplasmosis	3/113	0.9261680268010687	1.0	0	0	0.5309734513274336	0.04072545470868394	CASP9;TYK2;BIRC2
Pathways in cancer	20/530	0.9262391979627529	1.0	0	0	0.7547169811320754	0.05782850155345573	GSTM4;SMAD2;TCF7L1;MAP2K2;MAX;MMP1;WNT5A;F2;EPOR;CASP9;FRAT1;CCND2;WNT11;MSH2;CCND1;DVL2;BAX;SKP2;BIRC2;FGF22
Cytokine-cytokine receptor interaction	10/294	0.9265389941113686	1.0	0	0	0.6802721088435374	0.05190418135808088	CSF2;IFNL1;CCL4;BMP8A;CCL3;CCL18;IL17D;IL17C;EPOR;IL17RA
Hypertrophic cardiomyopathy (HCM)	2/85	0.9304527474425885	1.0	0	0	0.47058823529411764	0.03392187580644571	MYBPC3;ITGA11
Insulin secretion	2/86	0.9333063042418757	1.0	0	0	0.46511627906976744	0.032103177510297835	CREB3L3;GIP
Gap junction	2/88	0.9386840239616273	1.0	0	0	0.45454545454545453	0.028761981412220677	MAP2K2;TUBA8
Sphingolipid signaling pathway	3/119	0.9408414997698965	1.0	0	0	0.5042016806722689	0.030746516803698005	MAP2K2;BAX;PLD2
Salivary secretion	2/90	0.9436483877912323	1.0	0	0	0.4444444444444444	0.025778512347182387	AQP5;SLC9A1
Dilated cardiomyopathy (DCM)	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	MYBPC3;ITGA11
Morphine addiction	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	KCNJ5;PDE3A
mRNA surveillance pathway	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	DAZAP1;SAP18
NOD-like receptor signaling pathway	5/178	0.946680501203607	1.0	0	0	0.5617977528089887	0.030782934075452524	IRF7;RIPK1;TYK2;ATG12;BIRC2
Tuberculosis	5/179	0.9483516931062881	1.0	0	0	0.5586592178770949	0.029625620801920993	CASP9;PPP3CB;CR1;NFYC;BAX
Lysosome	3/123	0.9490704428624263	1.0	0	0	0.4878048780487805	0.02549866078547662	CLN3;CTSK;DNASE2
GnRH signaling pathway	2/93	0.9503836736321627	1.0	0	0	0.43010752688172044	0.021887960833825593	MAP2K2;PLD2
Oocyte meiosis	3/125	0.9527728742359944	1.0	0	0	0.48	0.023221790818524435	PPP3CB;SPDYC;BTRC
Long-term depression	1/60	0.95414298697788	1.0	0	0	0.3333333333333333	0.015647245745596144	MAP2K2
Steroid hormone biosynthesis	1/60	0.95414298697788	1.0	0	0	0.3333333333333333	0.015647245745596144	HSD11B2
Glycerolipid metabolism	1/61	0.956442628953957	1.0	0	0	0.32786885245901637	0.014601466257298934	PLPP2
Phosphatidylinositol signaling system	2/99	0.9616193258375976	1.0	0	0	0.40404040404040403	0.015812774876077424	ITPKB;IMPA2
Dopaminergic synapse	3/131	0.9624259105310855	1.0	0	0	0.4580152671755725	0.017541156574629197	KCNJ5;PPP3CB;CREB3L3
HIF-1 signaling pathway	2/100	0.9632369873558141	1.0	0	0	0.39999999999999997	0.014982321868347009	MAP2K2;NPPA
Inflammatory bowel disease (IBD)	1/65	0.9645452489317999	1.0	0	0	0.3076923076923077	0.011107241028940524	SMAD2
Mitophagy	1/65	0.9645452489317999	1.0	0	0	0.3076923076923077	0.011107241028940524	RRAS
Longevity regulating pathway	2/102	0.9662779974899206	1.0	0	0	0.39215686274509803	0.013452432976578837	CREB3L3;BAX
Chagas disease (American trypanosomiasis)	2/103	0.9677062755799263	1.0	0	0	0.38834951456310673	0.01274822216284486	SMAD2;CCL3
Epithelial cell signaling in Helicobacter pylori infection	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	ATP6V1E1
Glycolysis / Gluconeogenesis	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	PFKP
Staphylococcus aureus infection	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	CFD
Insulin signaling pathway	3/137	0.9702000312158441	1.0	0	0	0.43795620437956206	0.013249493867024583	SREBF1;SHC2;MAP2K2
Fluid shear stress and atherosclerosis	3/139	0.9724341820362676	1.0	0	0	0.4316546762589928	0.012065993490628802	PIAS4;GSTM4;SELE
Neuroactive ligand-receptor interaction	10/338	0.9761366952206109	1.0	0	0	0.5917159763313609	0.014291506389086826	KISS1;UCN;SCT;TAC4;RLN3;GHRL;TAC3;RLN1;F2;GIP
Leishmaniasis	1/74	0.9776904281936729	1.0	0	0	0.2702702702702703	0.00609789044447976	CR1
Thyroid hormone synthesis	1/74	0.9776904281936729	1.0	0	0	0.2702702702702703	0.00609789044447976	CREB3L3
Adrenergic signaling in cardiomyocytes	3/145	0.9782218699760653	1.0	0	0	0.41379310344827586	0.009111216728335437	MYL4;CREB3L3;SLC9A1
Pertussis	1/76	0.9798733026216075	1.0	0	0	0.2631578947368421	0.005350525977491548	C4BPA
Retrograde endocannabinoid signaling	3/148	0.9806622539772427	1.0	0	0	0.40540540540540543	0.007916418722549444	KCNJ5;NDUFB10;SLC17A7
Antigen processing and presentation	1/77	0.9808833558575986	1.0	0	0	0.2597402597402597	0.00501343630948899	NFYC
Non-alcoholic fatty liver disease (NAFLD)	3/149	0.981416039698096	1.0	0	0	0.40268456375838924	0.007553883933884644	SREBF1;NDUFB10;BAX
Phagosome	3/152	0.9835125918696039	1.0	0	0	0.3947368421052631	0.006562436097584378	ATP6V1E1;RILP;TUBA8
Platelet activation	2/124	0.987173993434516	1.0	0	0	0.3225806451612903	0.004164183852806964	F2;MYL12B
Herpes simplex virus 1 infection	15/492	0.9876632955714929	1.0	0	0	0.6097560975609756	0.007569166630307924	ZNF382;EIF2AK4;TYK2;CASP9;IRF7;BAX;ZNF689;ZNF700;ZNF599;ZNF555;ZNF554;ZNF256;ZNF124;BIRC2;ZNF761
RNA transport	3/165	0.9902524297509061	1.0	0	0	0.3636363636363636	0.0035619595668696115	NUP210L;TACC3;SAP18
Oxidative phosphorylation	2/133	0.9914288561400509	1.0	0	0	0.3007518796992481	0.0025888984552419132	NDUFB10;ATP6V1E1
Alzheimer disease	3/171	0.9923785722862302	1.0	0	0	0.3508771929824561	0.0026844277926789998	CASP9;PPP3CB;NDUFB10
Amoebiasis	1/96	0.9928157700996559	1.0	0	0	0.20833333333333331	0.0015021168229316978	CSF2
Circadian entrainment	1/97	0.993176581718741	1.0	0	0	0.20618556701030927	0.001411712214835502	KCNJ5
Progesterone-mediated oocyte maturation	1/99	0.9938447802854349	1.0	0	0	0.20202020202020202	0.0012473214492474535	SPDYC
Cholinergic synapse	1/112	0.9968503216903181	1.0	0	0	0.17857142857142855	5.633301761622566E-4	CREB3L3
Spliceosome	1/134	0.99898625000142	1.0	0	0	0.14925373134328357	1.5138271502198073E-4	HNRNPC
Calcium signaling pathway	2/188	0.9993161305762219	1.0	0	0	0.21276595744680848	1.4555390832707665E-4	ITPKB;PPP3CB
Olfactory transduction	7/444	0.999963329110907	1.0	0	0	0.31531531531531526	1.1563104973212517E-5	OR8B12;OR2AT4;OR10Q1;OR7C1;OR5B17;OR51A7;OR7E24
